INIS
administration
15%
adrenergics
17%
adults
18%
analgesics
5%
animals
9%
blood pressure
5%
burns
100%
children
15%
communities
15%
comparative evaluations
7%
control
18%
data
7%
dbp
7%
diseases
15%
exercise
15%
growth
15%
herpes simplex
5%
humans
17%
hypertrophy
15%
inflammation
17%
injuries
53%
investigations
5%
kinases
8%
levels
5%
mice
15%
morbidity
5%
mortality
10%
oxidation
15%
patients
32%
peaks
5%
pediatrics
6%
production
6%
proteins
9%
rats
31%
receptors
18%
reviews
19%
surface area
7%
surgery
19%
viruses
15%
Medicine and Dentistry
Age
5%
Cardiovascular System
15%
Child
15%
Clinician
6%
Combination Therapy
5%
Complication
7%
Comprehension
6%
Cytomegalovirus
8%
Development
12%
Drug
5%
Growth Disorder
15%
Heart Function
5%
Heart Ventricle Remodeling
15%
Heart Work
5%
Herpes Simplex Virus
15%
Inflammatory Bowel Disease
15%
Injury
7%
Morbidity
9%
Mortality
13%
Oxandrolone
15%
Oxidative Stress
15%
Patient
27%
Propranolol
15%
Surgery
15%
Systematic Review
15%
Testosterone
5%
Therapeutic Procedure
6%
Thermal Burn
46%
Treatment Response
5%
Ventricular Hypertrophy
15%
Pharmacology, Toxicology and Pharmaceutical Science
Adrenergic Receptor
20%
Buprenorphine
15%
Burn
52%
Cyclic AMP
5%
Cyclic AMP Dependent Protein Kinase
5%
Cytomegalovirus
8%
Drug
5%
Growth Disorder
15%
Heart Ventricle Hypertrophy
15%
Heart Ventricle Remodeling
15%
Herpes Simplex Virus
15%
Injury
6%
Morbidity
9%
Mortality
13%
Mouse Model
15%
Oxandrolone
15%
Propranolol
15%
Protein
5%
Rat
15%
Rat Model
16%
Sustained Release
15%
Testosterone
5%